Acceleron Pharma Inc
Most Recent
Acceleron Pharmaceuticals and Celgene Rise on Meeting Study Goals
Today, Celgene (CELG) and Acceleron Therapeutics (XLRN) stocks are trending higher on the news of their Phase 3 clinical trial for luspatercept meeting its goal.
